This month's profile groups:
Obecure Ltd. Also see "Obecure Ltd." - Scrip, 1 July, 2007. hopes that its de-risked drug-repositioning approach to treating obesity will overcome the growing hurdles to prove drug safety....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?